2025-03-27
Wegovy sales took a hit this year. Novo's CEO blames off-brand competition
Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy took a hit due to rising competition from off-brand, or compounded, versions of the treatment, according to the Danish pharma giant’s CEO Lars Fruergaard Jørgensen.
[...]Rating
Innovation
Pricing
Technology
Usability
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
2025-05-16
Novo Nordisk's CEO is out after the Ozempic maker's stock dropped 50% in a year
Novo Nordisk (NVO) CEO Lars Fruergaard Jørgensen will step down after eight years at the helm of the Danish pharmaceutical giant responsible for the blockbuster drugs Ozempic and Wegovy, the company [...]
2025-08-30
The best Labor Day sales for 2025: Tech from Apple, Dyson, Sony and others is up to 50 percent off
Labor Day marks the unofficial end to summer as the weather starts to get crisper and students head back to school for the new semester. It also marks a good time to check out the tech deals available [...]
2025-09-01
The best Labor Day sales for 2025: Get up to $500 off gear from Apple, Dyson, Shark, Sony and others
Labor Day is here, marking the unofficial end to summer as the weather starts to get crisper and students head back to school for the new semester. It also marks a good time to check out the tech deal [...]
2025-03-28
Cheaper Wegovy, 23andMe shutters, and RFK Jr. cuts FDA jobs: Pharma news roundup
Novo Nordisk is expanding its cash-only savings program offering its blockbuster weight-loss drug Wegovy for $499 a month at all U.S. pharmacies. 23andMe has filed for Chapter 11 bankruptcy protection [...]
2025-08-28
The best Labor Day sales for 2025: Get up to 50 percent off gear from Apple, Dyson, Sony and others
Labor Day marks the unofficial end to summer as the weather starts to get crisper and students head back to school for the new semester. It also marks a good time to check out the tech deals available [...]
2025-03-07
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup
Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical tr [...]
2025-05-30
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]